Treatment of acquired immunodeficiency syndrome-related lymphoma with a standard chemotherapy regimen

Annals of Hematology

Volumn 78, Issue 1, 1999, Pages 9-12

  Aviles A ^a   Nambo, M J ^a   Halabe, J ^b  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

^b Specialists Hospital   (Mexico)

Author keywords

Acquired immunodeficiency syndrome; Chemotherapy; Granulocyte colony stimulating factor; Malignant lymphoma; Non Hodgkin's lymphoma

Indexed keywords

BETA 2 MICROGLOBULIN; BLEOMYCIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BONE MARROW SUPPRESSION; FEMALE; GRANULOCYTOPENIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE COUNT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NAUSEA; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROGNOSIS; SUBCUTANEOUS DRUG ADMINISTRATION; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT FAILURE; TUMOR GROWTH; VOMITING;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ACTUARIAL ANALYSIS; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; EPIRUBICIN; FEMALE; HUMANS; LYMPHOMA, AIDS-RELATED; MALE; MIDDLE AGED; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VINCRISTINE;

EID: 0032996690     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050464     Document Type: Article

References (12)

1. Avilés, Delgado S, Nambo MJ, Alatriste S, Díaz-Maqueo JC (1994) Adjuvant radiotherapy to sites of previous bulky disease in patients with stage IV diffuse large cell lymphoma. Int J Radiat Oncol Biol Phys 30:799-804
2. Kaplan LD, Strauss DJ, Testa MA, et al (1997) Low-dose compared to standard dose m-BACOP chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. N Engl J Med 336:1041-1048
3. Knowles DM (1996) Etiology and pathogenesis of AIDS-related lymphoma. Hematol Oncol Clin North Am 10:1081-1109
4. Levine AM (1992) Acquired immunodeficiency syndrome-related lymphoma. Blood 80:8-20
5. Levine AM, Sullivan-Hairley J, Pike MC, et al (1991) Human immunodeficiency virus-related lymphoma. Prognostic factors predictive for survival. Cancer 68:2466-2472
6. Ribas A, Bellmont J, Albanel J, et al (1995) Malignant lymphoproliferative disease in HIV-seropositive patients. Acts Oncol 34:75-82
7. Sandler AS, Kaplan L (1996) AIDS-lymphoma. Curr Op Oncol 8:377-385
8. Sparano JA, Wiernick PH, Stracik M, et al (1993) Infusional cyclophosphamide,doxorubicin and etoposide in human immunodeficiency virus and human T-cell leukemia virus type I related non-Hodgkin's lymphoma. A highly active regimen. Blood 81:2813-2818
9. Sparano JA, Wiernick PH, Hu X, et al (1996) Pilot trial of infusional cyclophosphamide, doxorubicin and etoposide plus didanoside and filgrastin in patients with human immunodeficiency virus associated non-Hodgkin's lymphoma. J Clin Oncol 14:3026-3035
10. The International Non-Hodgkin's Lymphoma Prognostic Factor Project (1993) A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329:987-994
11. Tirelli V, Vacher E, Zagonel V et al (1995) CD-30 (Ki-y) positive anaplastic large-cell lymphoma in 13 patients with and 27 patients without human immunodeficiency virus infection. The first comparative clinicopathological study from a single institution that also included 80 patients with other immunodeficiency virus-related systemic lymphomas. J Clin Oncol 13:373-380
12. Vacher E, Tirelli V, Spina M, et al (1996) Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodefiency virus-related non-Hodgkin's lymphomas. A single institution study of 96 cases. J Clin Oncol 14:2217-2223